The global life science analytics market was valued at USD 9.0 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 7.6% from 2023 to 2030. This growth is primarily driven by the life sciences industry’s increasing reliance on analytics. Life sciences organizations are using descriptive and reporting analytics to build extensive databases and leveraging prescriptive and predictive analytics to forecast trends and outcomes. This analytics integration is crucial for enhancing decision-making and is expected to propel the market forward.
One of the significant factors contributing to this growth is the rising impact of social media and internet usage, which enhances patient engagement and influences the adoption of analytical solutions across the life sciences sector. Healthcare facilities and life science organizations are increasingly adopting analytics to improve clinical, financial, and operational outcomes. These analytics solutions help to optimize resource use and minimize healthcare expenses, adding momentum to the market's expansion.
Life science companies are using advanced analytics for various operational functions, including supply chain management, research and development (R&D), clinical trial design, regulatory compliance, sales, marketing, and pharmacovigilance. The widespread adoption of big data analytics and data mining techniques allows these organizations to identify and manage high-risk populations, thereby supporting informed strategic decisions. Government bodies and healthcare financing organizations also rely on predictive analytics to manage claims, prevent fraud, and improve cost efficiencies, further driving market growth.
Gather more insights about the market drivers, restrains and growth of the Life Science Analytics Market
The COVID-19 pandemic placed unprecedented pressure on healthcare systems, highlighting the need for advanced technologies to support the digital transformation of healthcare. During this time, there was a significant surge in the demand for analytical solutions in life sciences. Analytics played a critical role in managing vaccines, medical supplies, medicines, and other essential resources. This heightened demand during the pandemic has accelerated the adoption of life science analytics solutions across various sectors within the industry.
Furthermore, there is an increasing need for personalized medication, which relies on analyzing diverse human genome combinations and leveraging datasets generated through eHealth, mHealth, and electronic health records (EHR). The application of analytics in these areas aims to enhance patient care and treatment customization. As a result, companies in the market are developing strategies to incorporate artificial intelligence-based algorithms into data analytics. This integration allows organizations to mine valuable information from health datasets, enabling tailored treatment approaches and improving patient outcomes.
End-user Segmentation Insights:
In 2022, the pharmaceutical sector dominated the life science analytics market, accounting for a revenue share of over 46.7%. This dominance is attributed to the sector’s adoption of analytical solutions to improve resource management, drug discovery, and development processes, as well as to streamline clinical trials and drug utilization. For example, SAS Institute, Inc.’s SAS Life Science Analytics Framework was utilized in November 2020 to support the management of COVID-19 vaccine clinical trials. This framework allowed real-time data transformation, delivering data-enriched insights to enhance trial outcomes.
Biotechnology companies are expected to exhibit the fastest growth rate in the market, with a projected CAGR of 8.7% over the coming years. This rapid growth can be attributed to the increased adoption of analytical solutions in genome sequencing and analysis. Personalized data analytics solutions are also fueling the biotechnology segment’s expansion by facilitating precision medicine and personalized treatment plans. For instance, in May 2021, a partnership between Wipro and Transcell Oncologies aimed to improve vaccine safety assessments. This collaboration leveraged Transcell’s advanced stem cell technology alongside Wipro Holmes’ augmented intelligence platform to enhance vaccine research, safety, and efficacy assessments.
In conclusion, the growing application of analytics across various functions within life sciences, along with advancements in technology and data processing capabilities, is driving significant growth in the life science analytics market.
Order a free sample PDF of the Life Science Analytics Market Intelligence Study, published by Grand View Research.